ANDA 74279, held by Watson Labs Inc. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74279 (Dobutamine Hydrochloride), held by Watson Labs Inc, was first approved by FDA on Feb 18, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 18, 1998 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 12.5MG BASE/ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Dec 8, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Feb 18, 1998 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters